Activism without proxy fights is like ‘Catholicism without hell’: Loeb

An older, wiser Dan Loeb reckons his activist approach has changed, but the Wall Street icon will never put away the big stick.
Picture: Katje Ford

Anthony Macdonald

Activism without proxy fights is like ‘Catholicism without hell’: Loeb

November 14, 2025
An older, wiser Dan Loeb reckons his activist approach has changed, but the Wall Street icon will never put away the big stick.
Read Transcript

Renowned activist investor Dan Loeb is older, wiser and changed when it comes to the types of companies he targets and how he goes about it.

He’s friendlier, more constructive and much less public in his campaigns, he says. He’s chasing bigger targets – a necessity when you’re running much more money – is more focused on capital allocation and reckons he’s even welcomed by CEOs who may need an outsider to nudge a reluctant board.

Dan Loeb’s letters are the stuff of investing legend.  David Rowe

“They actually encourage us to write the letter,” he says.

Loeb says he has discovered that this activism – a less public version – can be very influential. He says he’s getting traction by going after companies’ margins, expenditure and strategies, making the scathing letters and public campaigns much less common.

“What we do is mostly behind the scenes,” the headline act at this year’s Sohn Hearts & Minds conference said on Friday.

‘Our little trade secret’

It struck us as a maturing of a Wall Street spear thrower.

But there’s one part of the activist toolkit he says he will never put away: the proxy fight.

“Corporations without bankruptcy [are] like Catholicism without hell,” he said. “I’d say the same thing about activism.

“Activism without the potential of a proxy contest doesn’t work, so we keep that in our back pocket, our little trade secret.”

So, Loeb says he’s firing in these proxy requests, but now often quietly. He cites new Domain-owner CoStar as an example – no one knew there was an activism campaign under way until the company announced a standstill between Third Point and DE Shaw and two new directors for its board.

Loeb’s letters are the stuff of investing legend; they were often personal, aimed at specific directors or executives, and used colourful language including “CVD” or chief value destroyer and “LSC” or “lucky sperm club”.

It’s interesting because what happens on Wall Street eventually makes its way into Australian capital markets.

Anthony Scaramucci (left) and Dan Loeb at the Sohn Hearts & Minds conference in Sydney on Friday.  Renee Nowytarger

Bankers for years have told us to expect large-scale activism and although it didn’t really come – except Grok’s run against AGL Energy’s demerger and board, which was unlike anything seen in this market since – there’s plenty of behind-closed-doors activism bubbling away.

Look at James Hardie Industries and its protest votes.

Look at Ramsay Health Care and Aurizon Holdings’ potential asset sales.

Look at Orora backing a change to its constitution to prevent a large scrip M&A deal.

Look at Macquarie Group’s first strike, CSL’s second strike and all the other mini proxy battles that are a feature of this AGM season.

Upbeat on US economy

What we haven’t seen – and why we’d argue Australian directors don’t realise how good they’ve got it – is a proper proxy fight complete with boardroom change.

The closest we have is James Hardie, where a stunning three directors, including the chair, were not re-elected at last month’s annual general meeting. Investors are suggesting replacements, though it remains to be seen whether they get their way, too.

Loeb’s address was the highlight of a full day of stock pitches and thematic panels at Sohn. The organisers kept Loeb until after lunch, and he didn’t disappoint.

He gave a pretty upbeat view of the US economy and even the AI sector, saying there was a bubble but at the neocloud/provider level (he called out CoreWeave, for example) rather than the Microsoft/Amazon/Nvidia end of town.

He seemed less fiery than his address at the same conference two years ago, perhaps showing how his activism approach has changed.

He spoke about company and management culture (he likes CEOs “willing to roll up their sleeves” and is worried by any chief executive who has their own elevator) and taking his business back into credit, where it all began.

The lesson, though, was his point about activism. Just because the nasty letters and public campaigns have vanished from the headlines, don’t think battles are not brewing below the surface.

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Renowned activist investor Dan Loeb is older, wiser and changed when it comes to the types of companies he targets and how he goes about it.

He’s friendlier, more constructive and much less public in his campaigns, he says. He’s chasing bigger targets – a necessity when you’re running much more money – is more focused on capital allocation and reckons he’s even welcomed by CEOs who may need an outsider to nudge a reluctant board.

Dan Loeb’s letters are the stuff of investing legend.  David Rowe

“They actually encourage us to write the letter,” he says.

Loeb says he has discovered that this activism – a less public version – can be very influential. He says he’s getting traction by going after companies’ margins, expenditure and strategies, making the scathing letters and public campaigns much less common.

“What we do is mostly behind the scenes,” the headline act at this year’s Sohn Hearts & Minds conference said on Friday.

‘Our little trade secret’

It struck us as a maturing of a Wall Street spear thrower.

But there’s one part of the activist toolkit he says he will never put away: the proxy fight.

“Corporations without bankruptcy [are] like Catholicism without hell,” he said. “I’d say the same thing about activism.

“Activism without the potential of a proxy contest doesn’t work, so we keep that in our back pocket, our little trade secret.”

So, Loeb says he’s firing in these proxy requests, but now often quietly. He cites new Domain-owner CoStar as an example – no one knew there was an activism campaign under way until the company announced a standstill between Third Point and DE Shaw and two new directors for its board.

Loeb’s letters are the stuff of investing legend; they were often personal, aimed at specific directors or executives, and used colourful language including “CVD” or chief value destroyer and “LSC” or “lucky sperm club”.

It’s interesting because what happens on Wall Street eventually makes its way into Australian capital markets.

Anthony Scaramucci (left) and Dan Loeb at the Sohn Hearts & Minds conference in Sydney on Friday.  Renee Nowytarger

Bankers for years have told us to expect large-scale activism and although it didn’t really come – except Grok’s run against AGL Energy’s demerger and board, which was unlike anything seen in this market since – there’s plenty of behind-closed-doors activism bubbling away.

Look at James Hardie Industries and its protest votes.

Look at Ramsay Health Care and Aurizon Holdings’ potential asset sales.

Look at Orora backing a change to its constitution to prevent a large scrip M&A deal.

Look at Macquarie Group’s first strike, CSL’s second strike and all the other mini proxy battles that are a feature of this AGM season.

Upbeat on US economy

What we haven’t seen – and why we’d argue Australian directors don’t realise how good they’ve got it – is a proper proxy fight complete with boardroom change.

The closest we have is James Hardie, where a stunning three directors, including the chair, were not re-elected at last month’s annual general meeting. Investors are suggesting replacements, though it remains to be seen whether they get their way, too.

Loeb’s address was the highlight of a full day of stock pitches and thematic panels at Sohn. The organisers kept Loeb until after lunch, and he didn’t disappoint.

He gave a pretty upbeat view of the US economy and even the AI sector, saying there was a bubble but at the neocloud/provider level (he called out CoreWeave, for example) rather than the Microsoft/Amazon/Nvidia end of town.

He seemed less fiery than his address at the same conference two years ago, perhaps showing how his activism approach has changed.

He spoke about company and management culture (he likes CEOs “willing to roll up their sleeves” and is worried by any chief executive who has their own elevator) and taking his business back into credit, where it all began.

The lesson, though, was his point about activism. Just because the nasty letters and public campaigns have vanished from the headlines, don’t think battles are not brewing below the surface.

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 14, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
January 18, 2023

Claremont Global: Investment Case for Nike

Equity Mates are joined by Head of Claremont Global Bob Desmond to discuss his 2022 conference pick, Nike. In the episode Bob unpacks the key metrics, the bull case and the bear case for Nike.

Read More
January 5, 2023

Why Transurban will always be one step ahead of inflation

Loathed by motorists, but loved by investors. Transurban came under focus when Catherine Allfrey nominated the roads operator as her top pick at the recent Sohn Hearts & Minds Conference.

Read More
November 18, 2022

Behind the mega-themes shaping top stockpickers

These are the mega-themes the smartest minds in the market are now firmly getting behind which they believe can help them deliver outsized profits.

Read More
November 18, 2022

Don’t rush to invest yet, fund manager tells Sohn event

Fund manager turned anti-corruption campaigner Bill Browder is advising investors to hang on to their cash until central banks stop raising interest rates and the cost of living starts to come down.

Read More
November 18, 2022

Fund managers go global for top Sohn conference stock picks over Aussie companies

SH&M had before Friday’s event made more than $40m in collective donations to medical research.

Read More
November 18, 2022

Fundies and billionaires party in Hobart

Two hundred of Australia’s best and brightest money managers, bankers and entrepreneurs toasted the seventh Sohn Hearts and Minds conference at David Walsh’s MONA.

Read More
November 18, 2022

Hearts racing: Rich listers rendezvous for speed-dating style stock picking

A room filled with 700 of the country’s financial luminaries and billionaires is a difficult place to pitch an investment idea but it’s a great place to raise money for charity.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.